Hosted on MSN
Scholar Rock outlines Q3 2025 U.S. apitegromab launch plans amid regulatory progress and global expansion focus
Earnings Call Insights: Scholar Rock Holding Corporation (SRRK) Q2 2025 CEO David L. Hallal emphasized Scholar Rock is “scaling for the next phase of growth as a commercial stage fully integrated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results